Rheumatology Quarterly

Galenos Publishing House

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Rheumatology Quarterly is an open-access journal published by Galenos Publishing House in Türkiye, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Galenos Publishing House
ISSN
2980-1559
Country
Türkiye
Languages
english
Access
Open access
Articles in DOAJ
22
Declared review time
16 weeks
Declared peer-review model
double_blind
Official website
https://qrheumatol.com/

Index listings

  • DOAJ · 2025-05-21
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

22

Most recent article

11 months ago

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

113

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

2

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy9
Last DOAJ review date
2025-05-21
Added to DOAJ
2025-05-21
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
66%
ORCID iDs in current deposits
98%
Enrolled in Crossref Similarity Check
✓
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Sclerosis and Related Diseases
  • Spondyloarthritis Studies and Treatments
  • Spondyloarthritis Studies and Treatments
  • Systemic Lupus Erythematosus Research
  • Systemic Sclerosis and Related Diseases
Show all subjects (75)
  • Systemic Sclerosis and Related Diseases
  • Spondyloarthritis Studies and Treatments
  • Vasculitis and related conditions
  • Autoimmune and Inflammatory Disorders Research
  • Ocular Diseases and Behçet’s Syndrome
  • Pulmonary Hypertension Research and Treatments
  • Systemic Lupus Erythematosus Research
  • Inflammatory Myopathies and Dermatomyositis
  • Systemic Lupus Erythematosus Research
  • Inflammatory Myopathies and Dermatomyositis
  • Inflammasome and immune disorders
  • Musculoskeletal pain and rehabilitation
  • Psoriasis: Treatment and Pathogenesis
  • Sarcoidosis and Beryllium Toxicity Research
  • COVID-19 Clinical Research Studies
  • Psoriasis: Treatment and Pathogenesis
  • Vasculitis and related conditions
  • Inflammasome and immune disorders
  • Vasculitis and related conditions
  • Autoimmune and Inflammatory Disorders Research
  • Inflammasome and immune disorders
  • Otitis Media and Relapsing Polychondritis
  • Autoimmune and Inflammatory Disorders Research
  • Psoriasis: Treatment and Pathogenesis
  • Peripheral Neuropathies and Disorders
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Sarcoidosis and Beryllium Toxicity Research
  • Ocular Diseases and Behçet’s Syndrome
  • COVID-19 Clinical Research Studies
  • Connective tissue disorders research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Peripheral Neuropathies and Disorders
  • Sarcoidosis and Beryllium Toxicity Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Ocular Diseases and Behçet’s Syndrome
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 Clinical Research Studies
  • IgG4-Related and Inflammatory Diseases
  • Breast Lesions and Carcinomas
  • Cardiovascular Disease and Adiposity
  • Gout, Hyperuricemia, Uric Acid
  • Breast Lesions and Carcinomas
  • Peripheral Nerve Disorders
  • Natural Compounds in Disease Treatment
  • Autoimmune and Inflammatory Disorders
  • Salivary Gland Disorders and Functions
  • Inflammatory Biomarkers in Disease Prognosis
  • Cardiovascular Health and Disease Prevention
  • Immunodeficiency and Autoimmune Disorders
  • Osteomyelitis and Bone Disorders Research
  • Immunodeficiency and Autoimmune Disorders
  • Gout, Hyperuricemia, Uric Acid
  • Peripheral Nerve Disorders
  • Medical Imaging and Pathology Studies
  • Urticaria and Related Conditions
  • Breast Lesions and Carcinomas
  • Medical Imaging and Pathology Studies
  • Cardiovascular Disease and Adiposity
  • Urticaria and Related Conditions
  • Health Literacy and Information Accessibility
  • Health Literacy and Information Accessibility
  • Long-Term Effects of COVID-19
  • Orthopedic Surgery and Rehabilitation
  • Spine and Intervertebral Disc Pathology
  • Long-Term Effects of COVID-19
  • Orthopedic Surgery and Rehabilitation

Keywords (DOAJ)

  • rheumatology
  • rheumatic diseases
  • medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: